We exist to grow psychedelic science and medicine as an industry-leading supplier of pharmaceutical-grade natural psilocybin and synthetic psychedelic compounds.
Is to produce scalable, natural mushroom formulations for transformational human experiences.
Is to make possible a future whereby natural psychedelic alternatives aid a wide variety of mental health conditions.
Is to be the number one trusted, compassionate supplier of safe, natural EU-GMP-grade psilocybin and synthetic psychedelics in the world.
We are invested in providing the safest supply of natural and synthetic psychedelics to the international market.
We own 20,000 sq ft of state-of-the-art, technologically advanced cultivation and analytical facilities.
We are a top tier ingredient supplier of natural, pharmaceutical-grade psilocybin and functional mushrooms.
We research formulations and extraction methods and investigate molecular discovery with restricted psychedelic compounds.
We are invested in providing the safest supply of natural and synthetic psychedelics to the international market.
We own 20,000 sq ft of state-of-the-art, technologically advanced cultivation and analytical facilities.
We are a top tier ingredient supplier of natural, pharmaceutical-grade psilocybin and functional mushrooms.
We research formulations and extraction methods and investigate molecular discovery with restricted psychedelic compounds.
“The chemistry and manufacturing requirements set out under division 5 of the FDR require the investigational product to be of GMP quality. This means that any psilocybin product, including psilocybin mushrooms, used in a clinical trial must be manufactured according to GMP standards.”
We’re building something amazing as the only EU-GMP certified producer of natural psilocybin in North America. Our goal is to be the number-one trusted, compassionate supplier of safe psilocybin and synthetic psychedelics in the world.
We are committed to being a top-tier ingredient supplier of pharmaceutical-grade natural psilocybin and functional mushrooms.
We are creating a model where psilocybin and other psychedelic medicines are accessible to all who need them.
We are committed to being a top-tier ingredient supplier of natural, pharmaceutical grade psilocybin and functional mushrooms.
We are creating a model where psilocybin and other psychedelic medicines are accessible to all who need them.
Regulator Filings
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th